Selection of Neisseria gonorrhoeae ceftriaxone resistance using doxycycline post-exposure prophylaxis

Lancet Infect Dis. 2023 Aug;23(8):e268-e269. doi: 10.1016/S1473-3099(23)00359-6. Epub 2023 Jun 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Ceftriaxone* / pharmacology
  • Ceftriaxone* / therapeutic use
  • Doxycycline / therapeutic use
  • Drug Resistance, Bacterial
  • Gonorrhea* / drug therapy
  • Gonorrhea* / prevention & control
  • Humans
  • Microbial Sensitivity Tests
  • Neisseria gonorrhoeae
  • Post-Exposure Prophylaxis

Substances

  • Ceftriaxone
  • Doxycycline
  • Anti-Bacterial Agents